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During development they transiently overlap their terri- A Nuclear Strike against Listeria—
tories, which is later resolved through regulation of rela- The Evolving Life of LXRtive growth of body and neurites. Neurite-neurite repul-
sion is unlikely used here, as removal of ALM does not
affect growth extent of the PLM neurite. Despite these
differences, the same molecular machinery is used to LXRs are members of the nuclear receptor superfamily
achieve the same eventual purpose—in the case of ALM and function as master regulators of cholesterol me-
and PLM tiling, Sax-1/Sax-2 appear to regulate neurite tabolism. In the macrophage, they control cholesterol
termination as compared to Fry/Trc regulating terminal efflux and inhibit the transcription factor NF-B-medi-
branch turning. ated proinflammatory responses. In this issue of Cell,
Even in the case of the mammalian retina, where den- Joseph et al. (2004) discover surprising, protective
drite-dendrite interaction has been strongly implicated functions for LXR in innate immunity.
in tiling, other mechanisms may also contribute. Indeed
a recent study using genetic mutations in mice that Liver X receptors (LXRs) are members of the nuclear
remove a large fraction of RGCs showed that character- receptor superfamily that bind oxysterol metabolites
istic dendritic arbors can form without homotypic den- and heterodimerize with retinoid X receptors (Repa and
dritic contacts (Lin et al., 2004). Tiling is likely achieved Mangelsdorf, 2002). They emerged as key mediators
through sequential steps. Neurons of a given class may of cholesterol homeostasis following the discovery that
be generated in a defined space pattern; each class of LXR null mice develop enlarged, cholesterol-laden liv-
neurons may have an autonomous program to decide ers and elevated serum cholesterol levels upon expo-
roughly how large the dendritic tree should be; dendrite- sure to high-cholesterol diets. Indeed, LXRs function
dendrite interactions may then be used at the end stage as cholesterol sensors, coordinately regulating target
of dendritic growth to achieve the eventual tiling. genes for cholesterol efflux, bile acid production, and
For the first time, an evolutionarily conserved pathway lipid transport to maintain cholesterol homeostasis. The
for dendritic tiling involving Trc/Fry (Sax-1/Sax-2) has  isoform is relatively restricted to liver, macrophages,
been identified. These findings of Emoto et al. and Galle- kidney, adipose tissue, and the intestine, whereas the
gos and Bargmann raise several new questions. For  isoform is more broadly expressed. To date, this differ-
example, what proteins on the dendritic surface of class ence in distribution has been the major distinction be-
IV da neurons sense the like dendrite and transduce tween LXR isoforms, which have appeared function-
the signal to Trc/Fry? Is homotypic dendritic repulsion ally indistinct.
mediated by direct contact or short-range diffusible mol- The role of LXRs in macrophage biology, where LXR
ecules? Do Sax-1/Sax-2 transduce signals from the ex- and LXR are coexpressed, has been an area of signifi-
tracellular environment or are they part of an intrinsic cant progress. Work has particularly focused on the
developmental program? How does Fry regulate Trc? function of LXRs in atherosclerosis, a chronic inflamma-
What are the downstream effectors regulating dendritic tory disease driven by the foam cell macrophage. LXR/
tiling? Are mammalian homologs of these molecules  dual agonists potently inhibit atherogenesis in animal
essential for RGC dendritic tiling? Finally and perhaps models, and, conversely, transplantation of bone mar-
the most enigmatic of all, what allows dendrites of differ- row devoid of both LXR isoforms substantially hastens
ent neuronal types to distinguish self from nonself? atherosclerosis in mice (Joseph et al., 2002; Tangirala
et al., 2002; Terasaka et al., 2003). Taken together, data
suggest that LXR may protect against vascular diseaseTakahiro Chihara and Liqun Luo
not only through peripheral effects on cholesterol me-Department of Biological Sciences
tabolism but via direct activities within the atheroscle-Stanford University
rotic lesion. LXR drives cholesterol efflux from the mac-Stanford, California 94305
rophage through upregulation of the reverse cholesterol
Selected Reading transport protein ABCA1, and, unexpectedly, LXR miti-
gates macrophage inflammation via repression of NF-
Adler, P.N. (2002). Dev. Cell 2, 525–535.
B signaling (Figure 1) (Joseph et al., 2003; Venkate-
DeVries, S.H., and Baylor, D.A. (1997). J. Neurophysiol. 78, 2048– swaran et al., 2000).
2060.
In this issue of Cell, new studies deepen the ties be-
Emoto, K., He, Y., Grueber, W.B., Adler, P.N., Jan, L.Y., and Jan,
tween LXR and inflammation by uncovering a protectiveY.-N. (2004). Cell 119, this issue, 245–256.
role for LXR in immunity to Listeria monocytogenes, a
Gallegos, M.E., and Bargmann, C.I. (2004). Neuron 44, 239–249.
gram-positive bacteria implicated in serious food-borne
Grueber, W.B., Jan, L.Y., and Jan, Y.N. (2002). Development 129,
human illness, including gastroenteritis, meningitis, and2867–2878.
intrauterine fetal demise (Joseph et al., 2004). ListeriaGrueber, W.B., Ye, B., Moore, A.W., Jan, L.Y., and Jan, Y.N. (2003).
infects by escaping the phagolysosome to enter the cellCurr. Biol. 13, 618–626.
cytosol, where it multiplies and can spread directly fromJan, Y.N., and Jan, L.Y. (2003). Neuron 40, 229–242.
cell to cell. In experimental listeriosis, bacteria injectedLin, B., Wang, S.W., and Masland, R.H. (2004). Neuron 43, 475–485.
via the tail vein are routed to the liver and spleen, whereRockhill, R.L., Daly, F.J., MacNeil, M.A., Brown, S.P., and Masland,
most are destroyed by resident macrophages (Vazquez-R.H. (2002). J. Neurosci. 22, 3831–3843.
Boland et al., 2001). Surviving bacteria grow and infectSugimura, K., Yamamoto, M., Niwa, R., Satoh, D., Goto, S., Tani-
hepatocytes but are initially countered by the innateguchi, M., Hayashi, S., and Uemura, T. (2003). J. Neurosci. 23, 3752–
3760. antimicrobial defenses of macrophages and neutrophils
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that limit the Listeria burden. Later, approximately a
week following inoculation, activated macrophages and
acquired T cell immunity become key to successful Lis-
teria clearance (Vazquez-Boland et al., 2001). Hence,
breakdown of either early innate or later acquired de-
fenses can have perilous consequences during Liste-
ria infection.
Joseph et al. (2004) show that mice devoid of both LXR
isoforms (LXR/) are more susceptible to Listeria
monocytogenes, developing higher bacterial burdens
with more frequent and accelerated demise following
infection. The susceptibility of LXR/ mice to Listeria
is observed in the days immediately following infection,
suggesting a defective innate immune response in dou-
ble-knockout animals. Interestingly, mice devoid of
LXR but not LXRmirror the susceptibility of LXR/
animals. Although inflammatory cytokines and other se-
rum mediators were not appreciably different between
LXR/ and control animals, gene expression analysis
identified SP/API6, a member of the scavenger recep-
tor cystine-rich repeat family, as a candidate susceptibil-
ity gene induced in wild-type and LXR/ but not Figure 1. LXRs: Cholesterol Sensors and Listeria Slayers
LXR/ or LXR/-infected livers. LXRs regulate diverse aspects of macrophage biology. LXR  and 
In an elegant series of experiments, Joseph and col- bind oxysterol metabolites and upregulate the ATP binding cassette
protein A1 (ABCA1), promoting cholesterol efflux. Both activatedleagues localize the immune defect in LXR/ mice,
receptor isoforms also suppress NF-B signaling, which may beuncover the basis for LXR null susceptibility, and es-
initiated by Toll-like receptors (TLRs), mitigating inflammation.tablish SP/API6 as a critical, LXR-specific target in-
Uniquely, LXR induces expression of SP/API6, a scavenger re-volved in Listeria infectious control (Joseph et al., 2004).
ceptor that inhibits macrophage apoptosis and promotes the killing
Transplantation of wild-type bone marrow into LXR/ of Listeria.
mice reversed vulnerability to Listeria infection and re-
stored expression of SP/API6, implicating marrow-
derived cells in the altered pathogen response of
LXR/ animals. This raised the possibility that mac- independent or related? Could LXR-mediated regula-
rophage defects may underlie the susceptibility of tion of SP/API6, for example, be important in the con-
LXR/ and LXR/ mice to Listeria infection. Within text of foam cell biology and atherosclerosis? Interest-
macrophages, LXR but not LXR levels are enhanced
ingly, LXR activation can simultaneously suppress
by infection with intracellular bacteria, including Listeria
production of the microbicidal mediator iNOS while en-
monocytogenes and Shigella flexneri. This induction is
hancing levels of a different antimicrobial protein, SP/
independent of the Toll-like receptor pathway but may
API6. Given these dichotomous effects, could LXR orbe regulated by NODs (nucleotide binding oligomeriza-
LXR ligands be helpful or detrimental to other innatetion domain proteins), a class of intracellular mediators
immune responses? Related lipid-sensing nuclear re-of immunity and apoptosis. Supporting this possibility,
ceptors known as peroxisome proliferator-activated re-treatment of macrophages with the NOD2 ligand mura-
ceptors (PPARs) mitigate inflammatory signals withinmyl dipeptide induces LXR expression, thus mimicking
the macrophage and other cell types (Lee et al., 2003;the effects of Listeria infection. How might LXR but not
Welch et al., 2003). Will the connection of LXR to innateLXR be protective during Listeria infection? Analysis
immunity emerge as a theme common to these andconfirmed that the SP/API6 promoter is preferentially
other nuclear receptors? If so, will inflammatory or anti-bound and activated by LXR relative to LXR. Func-
microbial pathways governed by various nuclear recep-tionally, this Listeria-induced LXR-SP/API6 transcrip-
tors be unique or overlapping? The answers to these andtional cascade proves to be important. Listeria-infected
other questions will undoubtedly open new chapters inmacrophages have higher bacterial burdens and in-
the life of LXR and its nuclear siblings.creased apoptosis in the setting of LXR deficiency,
while forced overexpression of either LXR or SP/API6
diminishes bacterial loads and improves cell survival. Acknowledgments
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